Search

everythinglearnresearchcommunity

for

Search:↓

5-aminosalicylic acid enemas may cause hair loss.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

MRL/MpJ mice heal burns slower with more scarring and less tissue regeneration than BALB/c mice.

Some herbal medicines can interfere with chemotherapy, affecting treatment and causing side effects.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Scalp cooling effectively reduces hair loss from chemotherapy.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Soft-tissue calcification is rare in systemic lupus erythematosus.

Monilethrix is a genetic hair disorder causing fragile, beaded hair with no effective treatment.

Autoimmune myopathy may be linked to hair loss and skin depigmentation.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Melatonin may protect against cell damage in pancreatitis.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

A woman with lupus had muscle weakness due to kidney issues and was successfully treated with medication.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

A patient with a severe scalp burn developed chronic bone infection, treated with surgery and muscle-skin flap from the back.

High doses of minoxidil can harm marmoset hearts and kidneys, possibly affecting humans similarly.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Some cancer treatments can cause permanent hair loss.

Scalp cooling does not stop hair loss from radiotherapy.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Tranexamic acid turns white hair brown in certain mice by affecting specific proteins.